-
Discovery of Microbiome Biomarkers for Parkinson's Disease
… tract — influences the development of the nervous system, affects behavior and contributes to various disorders of the nervous system. Because non-genetic factors appear to play a role in …
-
Sphingolipid and Alpha-synuclein Interactions
… on alpha-synuclein folding. We are studying a simplified system in which sphingolipid can be maintained at more … sources could be undertaken using the current experimental system in order to identify compounds that would prevent …
-
Generation of a dorsal motor nucleus X (DMX) specific pre-clinical model of alpha synuclein overexpression to study the etiology of autonomic dysfunction in PD
… the brain stem as the first region in the central nervous system to be affected by alpha-synuclein aggregation. Since DMX is an integral part of the autonomic nervous system, it is postulated that damage to this brain region …
-
Development of an HTS Assay to Break the Alpha-Synuclein-Glucocerebrosidase Feedback Loop
… alpha-synuclein and glucocerebrosidase in a range of cell systems including PD patient–derived cells. Furthermore, … drug discoverers through provision of a quantitative assay system which can been screened for new candidate drugs for …
-
Development of a mGluR4 Therapeutic for Parkinson's Disease
… to find alternatives to the stimulation of the dopaminergic system through levodopa and dopamine agonists, as long-term … the glutamate receptor mGluR4, which bypasses the dopamine system, leads to functional improvement in pre-clinical …
-
Enhancing Treatment Efficacy by Eliminating L-dopa Metabolizing Gut Bacteria
… effectiveness as a PD treatment. Study Design: Using a system for growing bacteria, we will cultivate the L-dopa … viruses can trigger any systemic or local immune responses that could limit its …